Clinical Trial Update: Treating Tinnitus Using Eutectic Mixture of Local Anesthetics (EMLA) 5% Cream [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating EMLA 5% cream (lidocaine/prilocaine) for tinnitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Tinnitus | Phase 4 | Status: COMPLETED